GSK2636771 structure, CAS 1372540-25-4

GSK2636771

CAS Number1372540-25-4

SynonymsGSK2636771; cc-414; CS-0747; QCR-187; 2-Methyl-1-[2-methyl-3-(trifluoromethyl)benzyl]-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid; GSK-2636771

Molecular FormulaC22H22O3N3F3

Molecular Weight433.43

Purity

Density1.4±0.1 g/cm3

Boiling Point641.3±55.0 °C at 760 mmHg

Melting Point

Flash Point

Appearance

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-1194157 Purity:
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 1372540-25-4 ] SDS Specification MoL

Chemical & Physical Properties
CAS Number1372540-25-4
Catalog No.2A-1194157
Chinese Name2-甲基-1-[[2-甲基-3-(三氟甲基)苯基]甲基]-6-(4-吗啉基)-1H-苯并咪唑-4-羧酸
SynonymsGSK2636771; cc-414; CS-0747; QCR-187; 2-Methyl-1-[2-methyl-3-(trifluoromethyl)benzyl]-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid; GSK-2636771
Molecular FormulaC22H22O3N3F3
Molecular Weight433.43
Density1.4±0.1 g/cm3
Boiling Point641.3±55.0 °C at 760 mmHg
Storage ConditionRoom temperature, dry, sealed
ApplicationGSK2636771 is a potent, selective and orally available PI3Kβ inhibitor with Ki and IC50 of 0.89 and 5.2 nM, respectively, 900-fold more selective than p110α and p110γ, and 10-fold more selective than
PubChem ID135656208
MDL NumberMFCD22417098
SMILESCc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F
InChIInChI=1S/C22H22F3N3O3/c1-13-15(4-3-5-18(13)22(23,24)25)12-28-14(2)26-20-17(21(29)30)10-16(11-19(20)28)27-6-8-31-9-7-27/h3-5,10-11H,6-9,12H2,1-2H3,(H,29,30)
InChI KeyXTKLTGBKIDQGQL-UHFFFAOYSA-N
MSDSmsds/195780_1_1372540_25_4.pdf
Transport InfoProduct name: GSK2636771
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA